WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s share price traded down 4.7% during trading on Thursday . The company traded as low as $14.52 and last traded at $14.52. 1,860 shares traded hands during trading, The stock had previously closed at $15.23.
WisdomTree BioRevolution Fund Stock Down 1.0 %
The company has a market cap of $2.16 million, a P/E ratio of 16.21 and a beta of 1.20. The business has a fifty day simple moving average of $15.77 and a two-hundred day simple moving average of $16.14.
Institutional Trading of WisdomTree BioRevolution Fund
An institutional investor recently bought a new position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC purchased a new position in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 13,134 shares of the company’s stock, valued at approximately $217,000. Jane Street Group LLC owned about 8.76% of WisdomTree BioRevolution Fund at the end of the most recent reporting period.
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Featured Stories
- Five stocks we like better than WisdomTree BioRevolution Fund
- Technology Stocks Explained: Here’s What to Know About Tech
- Micron Stock Under $100: Seize the AI-Driven Upside
- How to Invest in Insurance Companies: A Guide
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.